about
Proteogenomic characterization of human colon and rectal cancerCovalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cellsDesign, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS)Skyline: an open source document editor for creating and analyzing targeted proteomics experimentsAntioxidant chemistry of green tea catechins. New oxidation products of (-)-epigallocatechin gallate and (-)-epigallocatechin from their reactions with peroxyl radicals.RNA-seq data analysis at the gene and CDS levels provides a comprehensive view of transcriptome responses induced by 4-hydroxynonenalPeptide sequence motif analysis of tandem MS data with the SALSA algorithm.P-Mod: an algorithm and software to map modifications to peptide sequences using tandem MS data.proBAMsuite, a Bioinformatics Framework for Genome-Based Representation and Analysis of Proteomics Data.Alkylation of cytochrome c by (glutathion-S-yl)-1,4-benzoquinone and iodoacetamide demonstrates compound-dependent site specificity.Quantitative analysis by liquid chromatography-tandem mass spectrometry of deuterium-labeled and unlabeled vitamin E in biological samples.Identification of protein fragments as pattern features in MALDI-MS analyses of serum.Proteomics: clinical applications for head and neck squamous cell carcinoma.The poisons within: application of toxicity mechanisms to fundamental disease processes.Analysis of protein adduction kinetics by quantitative mass spectrometry: competing adduction reactions of glutathione-S-transferase P1-1 with electrophiles.Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.Protein damage by reactive electrophiles: targets and consequencesNetwork-assisted protein identification and data interpretation in shotgun proteomics.Comparative shotgun proteomics using spectral count data and quasi-likelihood modeling.Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry.Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancerPerformance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analyses.Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance.Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.Protein identification using customized protein sequence databases derived from RNA-Seq data.Cysteinyl peptide capture for shotgun proteomics: global assessment of chemoselective fractionation.Depletion of abundant plasma proteins and limitations of plasma proteomics.Site-specific mapping and quantification of protein S-sulphenylation in cells.DNA-protein cross-linking by 1,2,3,4-diepoxybutane.An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer.Identification of S-nitrosylation motifs by site-specific mapping of the S-nitrosocysteine proteome in human vascular smooth muscle cellsTargeted quantitation of proteins by mass spectrometry.A bioinformatics workflow for variant peptide detection in shotgun proteomicsProtein-selective capture to analyze electrophile adduction of hsp90 by 4-hydroxynonenal.Phosphotyrosine signaling analysis in human tumors is confounded by systemic ischemia-driven artifacts and intra-specimen heterogeneityPhosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition.Supporting tool suite for production proteomicsProteomic analysis of colon and rectal carcinoma using standard and customized databases
P50
Q28244320-F0E35FBD-FA15-482E-B1ED-C134131AC2DEQ28267411-0194D2C4-FA7E-4292-977A-CB3BE265B411Q28504783-5398A527-1D3E-4584-9803-91A304167F13Q28681060-5E309C16-67FE-4E8D-B89B-4E5590C7740FQ30080030-644FBB75-9C48-4CB4-A79A-5BA5E084310CQ30613149-3A243FEE-8D48-49B0-8629-56B8497325DFQ30668800-B75F2F02-8909-4579-BF76-496240AD6D03Q30670479-FA447189-D4BF-46A6-A77E-36CA758A024FQ30986912-E0D08DA1-6B95-4E7B-BA47-D046F6F10E46Q31031643-C30683BF-1268-4000-9328-036F06CDB767Q31141474-22531D05-1280-488A-9508-C89510E4972DQ31846468-7109D6D6-52A3-4E3A-AEAF-5A82B27DD594Q33224829-C3786102-4917-4085-9CB3-045F2AFD5236Q33233797-9211AB6E-746E-4B2F-891A-AADE96839FE5Q33243259-5FF8EFD5-E61D-4342-88AF-4A22BE7095FCQ33282058-A68C4B03-D7A3-472A-BEA5-20ECD93C1819Q33301109-867D2099-005A-4820-9AAA-3B3F72A7F9FEQ33308185-3665B8E6-0539-4C42-AB1F-CF72150C34B8Q33494813-4338EB4E-2616-41AD-ADD4-F17853EB63CBQ33619625-9A1E48A9-5738-49BE-8D54-85FA9A591521Q33639352-EDAF5381-5B90-4027-8CE0-D68064ACC7EEQ33643375-25233065-C145-4072-9ED2-E6FB9863EEF4Q33697726-BA2F74E6-5A68-4447-A3B6-2F86E740FED2Q33697735-855653B8-E3C7-4095-B236-2C6B8027EAA0Q33794491-9E4A96BD-0D77-4DA0-A245-B86DAF4678D8Q33850627-2363EBB1-2BAF-4C55-BAC4-3CD0029F20F0Q34079606-A25172B7-90E6-4117-914A-08AF2C55D356Q34167829-09CA420A-87C6-4DF6-9AAA-C5D6D49FD0C9Q34168719-E2A70659-DE75-489B-BFDD-31EA987696D8Q34204354-BAB0C598-7770-4D3D-87E5-05B04A0C0D02Q34206520-FA09E1BB-6A19-4724-AD29-4FF71910A818Q34503941-1C5F0FD3-B0F9-4231-90FB-95B190A39D8DQ34624562-8B145ED3-7B93-4F20-B805-E40DD57F7336Q34630866-327092D0-54BF-4835-A366-EB5B6BD1E62BQ34994365-6F6CFF1C-986D-403F-B56D-4820EE8A3425Q35164081-5CBEE65B-16F8-489D-A797-21F05A8A0908Q35251771-898AAF9A-3535-45A1-9493-1F1C924E029AQ35479665-2D7E055A-1562-4F38-9EB1-F0434A7E66E9Q35526673-369A095C-4B4B-4B62-9929-42B96A430FB2Q35770780-85B37B90-8C4C-4137-A217-3D30C74E4D22
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daniel C Liebler
@es
Daniel C Liebler
@nl
Daniel C Liebler
@sl
Daniel C. Liebler
@en
type
label
Daniel C Liebler
@es
Daniel C Liebler
@nl
Daniel C Liebler
@sl
Daniel C. Liebler
@en
prefLabel
Daniel C Liebler
@es
Daniel C Liebler
@nl
Daniel C Liebler
@sl
Daniel C. Liebler
@en
P106
P1153
7004797072
P2038
Daniel_Liebler
P21
P31
P496
0000-0002-7873-3031
P6023
2053487728